Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-20

FDA Approved: ZOLMITRIPTAN — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA's generic zolmitriptan for the acute treatment of migraine with or without aura (ANDA 204041).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)